St. Louis Financial Planners Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-27,134
Closed -$1.74M 23
2023
Q2
$1.74M Buy
27,134
+5,617
+26% +$377K 1.74% 18
2023
Q1
$1.49M Buy
+21,517
New +$1.52M 1.7% 31

Other funds holding BMY

St. Louis Financial Planners Asset Management's BMY Position: Q3 2023 in Review

St. Louis Financial Planners Asset Management sold out of Bristol-Myers Squibb (BMY) in Q3 2023, closing a stake of 27,134 shares — an estimated $1.74M sold.

St. Louis Financial Planners Asset Management first reported a position in BMY in Q1 2023 and held it in 2 quarters. The position peaked at $1.74M in Q2 2023. 2,388 funds tracked by Wall St. Rank hold BMY as of Q3 2023.

  • St. Louis Financial Planners Asset Management reported no remaining Bristol-Myers Squibb position as of Q3 2023 after selling out during the quarter.
  • St. Louis Financial Planners Asset Management sold 27,134 Bristol-Myers Squibb shares in Q3 2023, an estimated $1.74M.
  • St. Louis Financial Planners Asset Management first reported a position in Bristol-Myers Squibb in Q1 2023 and held it in 2 quarters.
  • St. Louis Financial Planners Asset Management's Bristol-Myers Squibb position peaked at $1.74M in Q2 2023.
  • 2,388 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.

Based on St. Louis Financial Planners Asset Management's 13F filing for Q3 2023, filed 6 Oct 2023.